Contents
pdf Download PDF
pdf Download XML
368 Views
1 Downloads
Share this article
Research Article | Volume: 28 Issue 1 (Jan-Dec, 2023) | Pages 1 - 3
Transcatheter Aortic Valve Replacement (TAVR): Expanding Indications to Low-Risk Patients
 ,
 ,
Under a Creative Commons license
Open Access
Published
Dec. 31, 2023
Abstract

Transcatheter aortic valve replacement (TAVR) has revolutionized the treatment of aortic stenosis, offering a less invasive alternative to surgical aortic valve replacement (SAVR). Initially reserved for high-risk and inoperable patients, TAVR has seen a rapid expansion in indications, including intermediate-risk and now low-risk populations. Recent clinical trials demonstrate the safety and efficacy of TAVR in low-risk patients, leading to shifts in clinical guidelines. This review explores the evolution of TAVR indications, focusing on its application in low-risk patients, clinical outcomes, and future directions.

Keywords
Recommended Articles
Research Article
Study of Thyroid Dysfunction among Hiv Infected Patients on Highly Active Anti-Retroviral Therapy (Haart): A Cross-Sectional Study
Published: 30/01/2025
The French paradox
Research Article
A Study on Lenth of Mesoappendix and Its Clinical Implication
...
Published: 25/10/2021
What is the role of increased heart rate in stable coronary artery disease
© Copyright Dialogues in Cardiovascular Medicine